Snowball logo
logo
CBI_logo

Clal Biotechnology Industries Ltd

CBI β€’ TA
β‚ͺ0.239-β‚ͺ0.004Β  (1.65%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
0.2240.370.1040.4330.835-
COGS
66.2421.87-0.6160.471-
Gross Profit
0.2240.370.104(0.183)0.364-
Operating Expenses & Income
Operating Income
(77.59)(27.42)(10.18)(6.345)(18.41)(4.506)
Total Operating Expenses
77.4712.2710.296.34518.784.506
R&D Expenses
33.0724.81----
Selling General & Admin Expenses
14.356.5115.4844.033.2513.251
Earnings from Continuing Operations
Interest Expense
(1.756)(3.725)(3.544)(3.395)(0.123)-
Interest Income
0.0370.0110.1310.1710.057-
Income Tax Expense
0.089114----
Net Income
Net Income
(89.58)(61.74)(31.05)(62.46)(13.32)(13.32)
Supplemental
EBIT
(77.59)46.57(24.55)(6.628)(20.05)(4.722)
EBITDA
(55.08)64.22(24.02)(6.345)(19.83)(4.506)
In millions of ILS, except % and values per 1 share